Funds Japanese medical education projects that train healthcare professionals in evidence-based prevention of pediatric infectious diseases and promote leadership in applying advanced vaccination and infection control strategies.
Funder: Pfizer Inc.
Due Dates: September 15, 2026 (Submission deadline, full application)
Funding Amounts: Up to 30,000,000 JPY per project; maximum project length is 2 years; overhead capped at 28%.
Summary: Supports independent medical education initiatives in Japan to develop healthcare professionals’ expertise in pediatric infectious disease prevention and implementation of advanced, evidence-based strategies.
Key Information: Applications must be submitted online after the new portal launches in mid-August 2026; late submissions will not be reviewed.
This grant opportunity funds independent medical education projects that aim to advance preventive strategies in pediatric infectious diseases within Japan. The primary goal is to develop healthcare professionals—including physicians, pharmacists, and nurses—with advanced expertise in epidemiological trends, vaccine effectiveness and safety, and both domestic and international vaccination guidelines (including maternal immunization). Supported projects should empower professionals to lead the nationwide implementation of evidence-based infectious disease prevention strategies, translating the latest scientific evidence into clinical and community healthcare practice. The program is designed to enhance the quality of pediatric infectious disease prevention systems by fostering leaders who can integrate and disseminate multifaceted knowledge and proactively improve infection control practices at regional and national levels.